2013Zhongguo yaofangRequires access

Clinical Observation of Different Dose of Atorvastatin Versus Simvastatin in the Treatment of Coronary Heart Disease in Elderly Patients with Hyperlipidemia

Fang Ca

Open publisher page 0 citations

Abstract

OBJECTIVE:To observe clinical efficacy and safety of different dose of atorvastatin vs.simvastalin in the treatment of coronary heart disease in elderly patients with hyperlipidemia.METHODS:150 elderly patients with coronary heart disease complicating with hyperlipidemia were randomly divided into observation group Ⅰ,observation group Ⅱ and control group with 50 cases in each group.Observation group Ⅰ was given atorvastatin 10 mg/d once a day;observation group Ⅱ was given atorvastatin 20 mg/d once a day half hour after a meal;control group was given simvastatin 20 mg/d half hour after supper.A treatment course lasted for 8 weeks,and the patients received one to 3 courses according to disease condition.Changes of blood lipid,total effective rate and the occurrence of ADR were compared between before treatment and 4 and 8 weeks after treatment.RESULTS:After 4 weeks of treatment,blood lipid levels of observation group Ⅰ,observation group Ⅱ and control group were decreased significantly than before(P0.05);there was no statistical significance among 3 groups(P0.05).After 8 weeks of treatment,blood lipid levels of 3 group were decreased significantly(P0.05),the level of TC,TG,LDL-C of observation group Ⅱ was significantly lower than that of observation group Ⅰ and control group(P0.05),and there was no statistical significance of the blood lipid in observation group Ⅰ and control group(P0.05).After 8 weeks,the toatal effective rate of observation group Ⅱ was much higher than that of observation group Ⅰ and control group,there was no statistical significance among 3 groups.There was no statistical significance in the incidence of ADR among 3 groups(P0.05).CONCLUSIONS:Therapeutic efficacy of atorvastatin is better than that of simvastatin in the treatment of senile coronary heart disease complicating with hyperlipemia,and have obvious dependence on dose.The higher dose is,the more obvious effect is;the ADR has no change and the clinical effect is safe and stable.

About this research paper

What this paper is about

OBJECTIVE:To observe clinical efficacy and safety of different dose of atorvastatin vs.simvastalin in the treatment of coronary heart disease in elderly patients with hyperlipidemia.METHODS:150 elderly patients with coronary heart disease complicating with hyperlipidemia were randomly divided into observation group Ⅰ,observation group Ⅱ and control group with 50 cases in each group.Observation group Ⅰ was given atorvastatin 10 mg/d once a day;observation group Ⅱ was given atorvastatin 20 mg/d once a day half hour after a meal;control group was given simvastatin 20 mg/d half hour after supper.A treatment course lasted for 8 weeks,and the patients received one to 3 courses according to disease condition.Changes of blood lipid,total effective rate and the occurrence of ADR were compared between before treatment and 4 and 8 weeks after treatment.RESULTS:After 4 weeks of treatment,blood lipid levels of observation group Ⅰ,observation group Ⅱ and control group were decreased significantly than before(P0.05);there was no statistical significance among 3 groups(P0.05).After 8 weeks of treatment,blood lipid levels of 3 group were decreased significantly(P0.05),the level of TC,TG,LDL-C of observation group Ⅱ was significantly lower than that of observation group Ⅰ and control group(P0.05),and there was no statistical significance of the blood lipid in observation group Ⅰ and control group(P0.05).After 8 weeks,the toatal effective rate of observation group Ⅱ was much higher than that of observation group Ⅰ and control group,there was no statistical significance among 3 groups.There was no statistical significance in the incidence of ADR among 3 groups(P0.05).CONCLUSIONS:Therapeutic efficacy of atorvastatin is better than that of simvastatin in the treatment of senile coronary heart disease complicating with hyperlipemia,and have obvious dependence on dose.The higher dose is,the more obvious effect is;the ADR has no change and the clinical effect is safe and stable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe clinical efficacy and safety of different dose of atorvastatin vs.simvastalin in the treatment of coronary heart disease in elderly patients with hyperlipidemia.METHODS:150 elderly patients with coronary heart disease complicating with hyperlipidemia were randomly divided into observation group Ⅰ,observation group Ⅱ and control group with 50 cases in each group.Observation group Ⅰ was given atorvastatin 10 mg/d once a day;observation group Ⅱ was given atorvastatin 20 mg/d once a day half hour after a meal;control group was given simvastatin 20 mg/d half hour after supper.A treatment course lasted for 8 weeks,and the patients received one to 3 courses according to disease condition.Changes of blood lipid,total effective rate and the occurrence of ADR were compared between before treatment and 4 and 8 weeks after treatment.RESULTS:After 4 weeks of treatment,blood lipid levels of observation group Ⅰ,observation group Ⅱ and control group were decreased significantly than before(P0.05);there was no statistical significance among 3 groups(P0.05).After 8 weeks of treatment,blood lipid levels of 3 group were decreased significantly(P0.05),the level of TC,TG,LDL-C of observation group Ⅱ was significantly lower than that of observation group Ⅰ and control group(P0.05),and there was no statistical significance of the blood lipid in observation group Ⅰ and control group(P0.05).After 8 weeks,the toatal effective rate of observation group Ⅱ was much higher than that of observation group Ⅰ and control group,there was no statistical significance among 3 groups.There was no statistical significance in the incidence of ADR among 3 groups(P0.05).CONCLUSIONS:Therapeutic efficacy of atorvastatin is better than that of simvastatin in the treatment of senile coronary heart disease complicating with hyperlipemia,and have obvious dependence on dose.The higher dose is,the more obvious effect is;the ADR has no change and the clinical effect is safe and stable.

Key concepts: Atorvastatin, Simvastatin, Medicine, Statistical significance, Hyperlipidemia, Blood lipids, Internal medicine, Coronary heart disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation of Different Dose of Atorvastatin Versus Simvastatin in the Treatment of Coronary Heart Disease in Elderly Patients with Hyperlipidemia — Research Paper | ScholarLens